We are a leading healthcare campus encompassing all fields of health: from healthcare and research to teaching and management.
Professionalism, commitment and research by professionals on the Campus are the key elements in offering patients excellent care.
We are committed to research as a tool to provide solutions to the daily challenges we face in the field of medical healthcare.
Thanks to our healthcare, teaching and research potential, we work to incorporate new knowledge to generate value for patients, professionals and the organization itself.
We generate, transform and transmit knowledge in all areas of the health sciences, helping to train the professionals of the future.
We are defined by our vocation for communication. We invite you to share everything that happens at Vall d'Hebron Barcelona Hospital Campus, and our doors are always open.
Hospital donations
Research donations
Dra. Lynne Postovit - Associate Professor, Sawin-Baldwin Chair in Ovarian Cancer, Department of Oncology -Division of Experimental Oncology - University of Alberta - Canada
"Cell plasticity in cancer"
Tumours contain populations of cells with stem cell like properties, and these phenotypically plastic cells are responsible for cancer recurrence and metastatic potential. Stem cell-like populations are regulated by dynamic niches, characterized by specific growth factors and extracellular matrices, as well as biophysical features such low oxygen tensions. Moreover, a growing body of evidence suggests that cancer cells co-opt stem cell-associated regulatory networks in order to sustain plasticity. For example, we have discovered that an embryonic-associated protein called Nodal maintains stem cell phenotypes in cancer, and that it promotes classical hallmarks of cancer such as angiogenesis, chemotherapy resistance invasion and metastasis. We have also found that biophysical features of a growing tumour, in particular hypoxia, can promote tumour cell plasticity by up-regulating embryonic proteins like Nodal via a combinatorial mechanism involving alterations in bivalent histone modifications as well as selective mRNA translation. Finally, we have determined that these complex interactions can be confounded by genetic variability leading to the expression of unique proteoforms. By studying the mechanisms by which cancer cells acquire and sustain phenotypic plasticity, we may uncover novel targets for the prediction and prevention of tumour progression.
Host: Translational Molecular Pathology stefan.hummer@vhir.org
The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”. Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health). Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information. Legal basis: Consent of the data subject. Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen. Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time. Source: The data subject. Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.